 Hikma Pharmaceuticals PLC AIM:HIK, OTC:HKMPF reported solid growth for 2021, with sales rising 9 on the back of a good performance in all its three businesses. The multinational pharmaceutical company also announced plans to return US300mln to shareholders via a share buyback. 